- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05171192
Culturally Adapted CMAP Plus LTP for Refugee Mothers with History of Self-harm in Pakistan
Feasibility Study of a Culturally Adapted Manual Assisted Brief Psychological Intervention (CMAP) Plus Learning Through Play (LTP) for Refugee Mothers with History of Self-harm in Pakistan
Objectives:
- To asses the feasibility and acceptability of a culturally adapted manual assisted brief psychological intervention (CMAP) plus Learning through Play (LTP) for refugee mothers with history of self-harm having children 0-33 months. (Integrated intervention called CMAP Plus)
- To assess if CMAP Plus will reduce the repetition of self-harm in refugee mothers having children aged between 0-33 months.
- To determine if the intervention improves infant development and maternal attachment.
- To explore participants experiences with the intervention.
Study design and setting:
This will be a feasibility cluster randomized control trial (cRCT) of culturally adapted CMAP Plus LTP intervention with refugee mothers from Quetta and Peshawar, Pakistan.
Sample size:
We aim to recruit a sample of 80 refugee mothers in the study.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Balochistan
-
Quetta, Balochistan, Pakistan, 87300
- Community settings
-
-
KPK
-
Peshawar, KPK, Pakistan, 25000
- Community settings
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18 years and above refugee mothers with children aged between 0-33 months.
- History of self-harm.
- Resident in the study site.
- Capacity to provide informed consent.
- Available for the duration of the study.
Exclusion Criteria:
- Unable to provide consent due to severe mental or physical illness.
- Unlikely to be available for the entire duration of the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CMAP Plus LTP added to TAU
C-MAP is a manual assisted intervention based on the principles of CBT which is focused on evaluation of the self-harm attempt, crisis skills, problem solving and basic cognitive techniques to manage emotions, negative thinking, and relapse prevention strategies. As family conflicts are a common issue with this group one session is focused on the use of culturally sensitive training in assertiveness and conflict management. The LTP is a community-based parenting intervention designed to deal with early child development. The central feature of the LTP intervention is a pictorial calendar devised for parents which depicts eight successive stages of child development from birth to 3 years along with illustrations of parent-child play and other activities that promote parental involvement, learning, and attachment. This will be added to Treatment as Usual |
The LTP Plus CMAP intervention will be delivered for a period of 12 weeks, including 8 weekly sessions and 2 sessions fortnightly.
First 6 sessions will be for a duration of 60-90 minutes and remaining 4 sessions will take approximately 50-60 minutes.
All sessions will be delivered by female therapists trained in CMAP and LTP intervention.
|
|
No Intervention: TAU alone
TAU alone will include routine follow up by Community Health Workers (CHWs) in Pakistan.
Their work includes assisting with all aspects of maternal, new-born and childcare.
Participants in treatment as usual arm will receive routine care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility measure
Time Frame: From baseline to 12th week (at the end of intervention)
|
The feasibility will be determined by collating data on recruitment and retention rates.
The success criterion of feasibility will be to recruit > 50% of eligible participants.
|
From baseline to 12th week (at the end of intervention)
|
|
Acceptability measure
Time Frame: From baseline to 12th week (at the end of intervention)
|
The intervention acceptability will be assessed using data on attendance.
Criterion for acceptability is a mean attendance rate of >70% of at least 7 sessions.
|
From baseline to 12th week (at the end of intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Suicide Attempt Self-Injury Interview
Time Frame: From baseline to 12th week
|
Repetition rate of self-harm at 3 months after randomisation as measured by adapted Suicide Attempt Self-Injury Interview.
The questionnaire records self-harm events by severity and chronological order.
|
From baseline to 12th week
|
|
Beck Scale for Suicide Ideation
Time Frame: Change in problem scores from baseline to 12th week
|
This is a 19-item instrument for detecting and measuring the current intensity of the patients' specific attitudes, behaviours, and specificity of a patient's thoughts to kill him/herself during the past week.
|
Change in problem scores from baseline to 12th week
|
|
Beck Depression Inventory
Time Frame: Change in problem scores from baseline to 12th week
|
This is a 21 items scale measuring symptoms of depression.
Higher scores on the scale indicate greater severity of depression.
|
Change in problem scores from baseline to 12th week
|
|
Beck Hopelessness Scale
Time Frame: Change in problem scores from baseline to 12th week
|
This instrument is designed to measure three aspects of hopelessness, feelings about the future, loss of motivation and expectations.
|
Change in problem scores from baseline to 12th week
|
|
Generalized Anxiety Disorder
Time Frame: Change in problem scores from baseline to 12th week
|
This is a 7-item scale used to screen for and measure severity of Generalized Anxiety Disorder.
|
Change in problem scores from baseline to 12th week
|
|
Assessment of the growth and development of children
Time Frame: Change from baseline to 12th week
|
Anthropometric measures of child growth will be collected through measuring children's height, weight and head circumference
|
Change from baseline to 12th week
|
|
Ages and Stages Questionnaire and ASQ Socio-emotional Scales
Time Frame: Change from baseline to 12th week
|
Ages and Stages Questionnaire and ASQ Socio-emotional scales will be used to measure child development.
Parents will report on their child's communication, gross motor, fine motor, problem solving and personal-social development at different time points.
|
Change from baseline to 12th week
|
|
Coping resource inventory
Time Frame: Change from baseline to 12th week
|
Coping resource inventory will assess the coping resources to manage stress available to an individual.
|
Change from baseline to 12th week
|
|
Problem Solving Inventory
Time Frame: Change in problem scores from baseline to 12th week
|
The Problem-Solving Inventory assesses an individual's awareness and evaluation of his or her problem-solving abilities or styles.
The problem-solving Inventory is a self-report measure, and thus assesses perceptions of problem solving as opposed to actual problem-solving skills.
|
Change in problem scores from baseline to 12th week
|
|
Infant Development Questionnaire
Time Frame: Change from baseline to 12th week
|
Infant Development Questionnaire is a 20-item questionnaire of paternal knowledge and expectations for child development in the first three years.
|
Change from baseline to 12th week
|
|
Parenting Stress Index - Short Form
Time Frame: Change from baseline to 12th week
|
Parents rated 36 item scale on five-point scale (1-5).
The scale consists of three subscales: (1) Parenting Distress, (2) Difficult Child Characteristics, and (3) Dysfunctional Parent-Child Interaction.
|
Change from baseline to 12th week
|
|
Multidimensional Scale of Perceived Social Support
Time Frame: Change from baseline to 12th week
|
This brief scale will assess perceived social support.
|
Change from baseline to 12th week
|
|
Euro-Qol-5 Dimensions scale
Time Frame: Change in problem scores from baseline to 12th week
|
Health-related quality of life will be measured using the Euro-Qol-5 Dimensions scale.
This is a standardized instrument that measures five health dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), each scored from 1 to 3 indicating "no problem" to "severe problems".
|
Change in problem scores from baseline to 12th week
|
|
Client Service Receipt Inventory
Time Frame: Change from baseline to 12th week
|
This inventory will collect information about the use of other health services (including the informal sector faith healers/Imams) using CSRI based on our previous work in Pakistan
|
Change from baseline to 12th week
|
|
Client Satisfaction Questionnaire
Time Frame: Change from baseline to 12th week
|
The participants will rate their satisfaction with treatment using the Client Satisfaction Questionnaire.
|
Change from baseline to 12th week
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Nasim Chahudhry, Pakistan Institute of Living and Learning
- Principal Investigator: Nusrat Husain, University of Manchester
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SAHAR M-CMAP Plus LTP-002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Child Development
-
SangathUNICEFCompletedChild Development | Child Nutrition and Early Child DevelopmentIndia
-
Yale UniversityRobinhood Foundation; Adelphi University; Docs for TotsCompletedSocial Skills | Child Behavior | Child Development | Infant DevelopmentUnited States
-
International Care Ministries, PhilippinesCompassion International, United States of AmericaNot yet recruitingChild Development | Child Nutrition, Child Neurobehavioral Development | Academic Attainment | Household and Family | Financial Wellbeing
-
University of Southern CaliforniaSafe Water and AIDS Project; Early Childhood Development Network for Kenya...Active, not recruitingChild Behavior | Child Development | Language, ChildKenya
-
Windward Islands Research and Education FoundationGrand Challenges Canada; St. George's University; GRENCASECompletedDevelopment, Child | Behavior, Child | Neurocognition, ChildGrenada
-
London School of Hygiene and Tropical MedicineInternational Centre for Diarrhoeal Disease Research, Bangladesh; University... and other collaboratorsActive, not recruitingChild Development | Child Development DisorderBangladesh, Tanzania, Nepal
-
Children's Hospital of PhiladelphiaNational Institute on Minority Health and Health Disparities (NIMHD)CompletedDevelopment Delay | Development, ChildUnited States
-
University of WashingtonRecruitingChild Behavior | Child DevelopmentUnited States
-
The Hospital for Sick ChildrenAga Khan University; March of DimesCompletedChild Development | Child Mortality | Child Morbidity | Child BehaviourPakistan
-
Universidade Federal de PernambucoCoordination for the Improvement of Higher Education PersonnelNot yet recruitingChild Development | Music Education | Early Child Development | Adaptive Behavior | Preschool EducationBrazil
Clinical Trials on CMAP Plus LTP
-
Pakistan Institute of Living and LearningUniversity of ManchesterCompletedSubstance-Related Disorders | Self HarmPakistan
-
Pakistan Institute of Living and LearningNot yet recruitingSuicidal Ideation | Trauma, Psychological
-
Pakistan Institute of Living and LearningGrand Challenges CanadaCompleted
-
Pakistan Institute of Living and LearningCompleted
-
Pakistan Institute of Living and LearningHealth and Nutrition Development Society; Hincks Dellcrest CentreCompleted
-
Pakistan Institute of Living and LearningCompletedDepression | Intellectual DisabilityPakistan
-
Pakistan Institute of Living and LearningCompleted
-
Pakistan Institute of Living and LearningCompletedMaternal DepressionPakistan
-
Pakistan Institute of Living and LearningRecruitingSelf Harm, First Episode PsychosisPakistan
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS)Completed